NovoHope Secures Official Patent Application Acceptance for Innovative Pet Healthcare Oral Film Technology
Published on November 16, 2026 • Corporate Announcements
Wuxi Nuohui Biotechnology Co., Ltd. (NovoHope) has officially received the Patent Application Acceptance Notice from the National Intellectual Property Administration (CNIPA) for its proprietary technology in pet healthcare oral films.
This patent acceptance marks a crucial step forward in our mission to revolutionize pet supplement delivery systems. By focusing on enhanced bioavailability and stress-free administration, NovoHope continues to push the boundaries of companion animal wellness.
Official Patent Application Details
| Invention Title | A Pet Healthcare Product Oral Film and Its Preparation Method |
| Applicant | Wuxi Nuohui Biotechnology Co., Ltd. |
| Application Number | 2026111634200 |
| Issuing Authority | National Intellectual Property Administration, PRC (CNIPA) |
Addressing Real Challenges in Pet Health Administration
Traditional oral dosage forms such as pills, capsules, and liquids often cause anxiety for pets and inconvenience for owners during daily supplementation. NovoHope’s proprietary oral film technology solves this pain point by offering:
- Rapid Dissolution: Dissolves quickly upon contact with oral mucosa without requiring water.
- High Bioavailability: Bypasses initial hepatic first-pass metabolism for efficient active ingredient absorption.
- Stress-Free Experience: Palatable formulation prevents rejection and dosage spitting.
Official Acceptance Notice Document Scan
CNIPA Official Notification Reference: 2026111634200
About Wuxi Nuohui Biotechnology Co., Ltd. (NovoHope)
NovoHope is a biotechnology company dedicated to science-backed pet health and premium care solutions. Through continuous research and innovative delivery technologies, we strive to elevate the quality of life for pets worldwide.
0 Comments